Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm

Circulation
C HeldB Wiman

Abstract

Disturbed fibrinolytic function may influence the progression of coronary atherosclerosis and contribute to thrombotic cardiovascular (CV) events. In the Angina Prognosis Study in Stockholm (APSIS), patients with stable angina pectoris were studied prospectively during double-blind treatment with metoprolol or verapamil. Various measures of fibrinolytic function were studied in 631 (of 809) patients. During a median follow-up time of 3.2 years (2132 patient-years), 32 patients suffered a CV death, 21 had a nonfatal myocardial infarction (MI), and 77 underwent revascularization. Plasma levels of tissue plasminogen activator (TPA) activity and antigen (ag), plasminogen activator inhibitor (PAI-1) activity at test, and TPA responses to exercise were determined at baseline and after 1 month's treatment and were related to subsequent fatal and nonfatal CV events. Univariate Cox regression analysis revealed that elevated levels of TPA-ag at rest (P < .05), high PAI-1 activity (P < .05), and low TPA-ag responses to exercise (P < .05) were associated with increased risk of subsequent CV death. After adjustment for baseline risk factors, TPA-ag independently predicted CV death or MI. In addition, PAI-1 activity independently predicted C...Continue Reading

References

Feb 1, 1990·Journal of Clinical Pharmacology·A C Teger-NilssonB Ablad
Apr 1, 1988·American Heart Journal·R B FrancisD I Feinstein
Sep 1, 1984·International Journal of Cardiology·O JohnsonT Nilsson
Aug 1, 1995·The American Journal of Cardiology·D BenchimolJ Bonnet
Jun 20, 1996·The American Journal of Cardiology·P HjemdahlN Rehnqvist

❮ Previous
Next ❯

Citations

Aug 7, 2007·European Journal of Applied Physiology·Tracy BaynardBo Fernhall
Sep 10, 2002·Current Hypertension Reports·Clive Rosendorff
Jun 15, 2000·The New England Journal of Medicine·H P Kohler, P J Grant
Jun 30, 2005·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Roberto Fogari, Annalisa Zoppi
Jul 5, 2001·Biochemical and Biophysical Research Communications·A M SawkaT O'Brien
Oct 13, 2014·The American Journal of Cardiology·Denise L SmithBo Fernhall
Oct 7, 2011·The Journal of Biological Chemistry·Andrey A KomissarovSteven Idell
May 1, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kristina KoppelEric Sandström
Jan 9, 2008·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Izzet Hosgor, Sarfraz Ahmad
Dec 28, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Mervyn D I VergouwenYvo Bwem Roos
Jan 27, 2005·Journal of Thrombosis and Haemostasis : JTH·P M MannucciF Peyvandi
Aug 18, 2004·International Journal of Clinical Practice·E Coban, M Ozdogan
Jan 3, 2013·European Journal of Clinical Investigation·Thomas KahanPaul Hjemdahl
Jun 27, 2013·Journal of Thrombosis and Haemostasis : JTH·N A GinglesR J Parmer
Dec 18, 2003·The American Journal of Medicine·Christopher J Lyon, Willa A Hsueh
Feb 17, 2005·Annals of Vascular Surgery·Philip S MullenixBenjamin W Starnes
May 12, 2000·Hematology/oncology Clinics of North America·B Wiman
Jun 9, 2001·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·P C HaggartA W Bradbury
May 12, 1998·Journal of Vascular Surgery·L A KillewichW R Flinn
Sep 27, 2006·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Ta-Chen SuKai-Jen Chuang
Aug 11, 2004·International Journal of Cardiology·Diederick E Grobbee, Michiel L Bots
Sep 20, 2005·Journal of the American College of Cardiology·Matthias FrickFranz Weidinger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.